Canada· CA-DIN-02473364
NEXGARD SPECTRA
A medicinal product containing milbemycin oxime + afoxolaner, registered in Canada by BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC..
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- MILBEMYCIN OXIME + AFOXOLANER
- Manufacturer
- BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
- Country
- Canada (CA)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Milbemycin oxime + afoxolaner in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/45689dcb-bcd7-495d-961f-a03f461ff83c GET /v1/drugs/45689dcb-bcd7-495d-961f-a03f461ff83c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02473364",
"form": "TABLET (CHEWABLE)",
"class": "Veterinary",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": null,
"schedule": [
"Prescription"
],
"drug_code": "96276",
"strengths": [
"1.9 MG",
"9.4 MG"
],
"ahfs_class": null,
"substances": [
"MILBEMYCIN OXIME",
"AFOXOLANER"
],
"product_categorization": null
}See everything about milbemycin oxime + afoxolaner.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.